Xu Wei

620 total citations
20 papers, 493 citations indexed

About

Xu Wei is a scholar working on Molecular Biology, Orthopedics and Sports Medicine and Surgery. According to data from OpenAlex, Xu Wei has authored 20 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Orthopedics and Sports Medicine and 6 papers in Surgery. Recurrent topics in Xu Wei's work include Bone health and osteoporosis research (8 papers), Bone Metabolism and Diseases (8 papers) and Hip and Femur Fractures (4 papers). Xu Wei is often cited by papers focused on Bone health and osteoporosis research (8 papers), Bone Metabolism and Diseases (8 papers) and Hip and Femur Fractures (4 papers). Xu Wei collaborates with scholars based in China, Poland and South Korea. Xu Wei's co-authors include Lin Wu, Xiaohong Wang, Farzin Farzaneh, Rui‐Hua Xu, Hao Shen, Yan‐Ming Xie, Gang Yao, Yili Zhang, Yan Chai and Junjie Jiang and has published in prestigious journals such as Small, Frontiers in Immunology and Environmental Research.

In The Last Decade

Xu Wei

17 papers receiving 483 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xu Wei China 9 193 147 102 66 56 20 493
Zemin Xiang China 12 154 0.8× 35 0.2× 48 0.5× 31 0.5× 21 0.4× 24 358
Mengjie Xiao China 14 280 1.5× 79 0.5× 48 0.5× 5 0.1× 22 0.4× 37 588
Deepkamal Karelia United States 11 150 0.8× 233 1.6× 68 0.7× 8 0.1× 40 0.7× 22 482
Zhou Yingfeng China 10 295 1.5× 29 0.2× 35 0.3× 12 0.2× 29 0.5× 11 527
Ákos Csonka Hungary 11 228 1.2× 110 0.7× 33 0.3× 9 0.1× 22 0.4× 33 405
Mohamed Ismail Egypt 13 212 1.1× 151 1.0× 93 0.9× 4 0.1× 23 0.4× 33 560
Won Hoon Jung South Korea 18 220 1.1× 209 1.4× 53 0.5× 7 0.1× 16 0.3× 40 720
Emad F. Eskander Egypt 10 145 0.8× 93 0.6× 22 0.2× 5 0.1× 60 1.1× 31 550
Magdalena Dmoszyńska‐Graniczka Poland 14 329 1.7× 57 0.4× 70 0.7× 4 0.1× 60 1.1× 25 551
Yu Xue United States 8 258 1.3× 41 0.3× 96 0.9× 10 0.2× 42 0.8× 9 677

Countries citing papers authored by Xu Wei

Since Specialization
Citations

This map shows the geographic impact of Xu Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xu Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xu Wei more than expected).

Fields of papers citing papers by Xu Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xu Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xu Wei. The network helps show where Xu Wei may publish in the future.

Co-authorship network of co-authors of Xu Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Xu Wei. A scholar is included among the top collaborators of Xu Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xu Wei. Xu Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wei, Xu, et al.. (2025). The burden of common neurological disorders in Asia: insights from the Global Burden of Disease Study (1990–2021). Journal of Neurology. 272(5). 333–333. 1 indexed citations
3.
Hong, Xiaoting, Min Zheng, Fan Lin, et al.. (2025). Bioinformatics based exploration of the anti-liver fibrosis mechanism of Pien Tze Huang via EGFR/JAK1/STAT3 pathway. Frontiers in Immunology. 16. 1665648–1665648.
4.
Zhang, Haitao, Jing Wang, Xia Meng, et al.. (2024). Parathyroid hormone mediates the adverse impact of air pollution exposure on serum 25-hydroxyvitamin D: A nationwide cross-sectional study in China. Environmental Research. 263(Pt 2). 120063–120063.
5.
Chen, Ming, Xiaoyang Wang, He Yin, et al.. (2023). Effect of Baduanjin exercise on primary osteoporosis: study protocol for randomized controlled trial. BMC Complementary Medicine and Therapies. 23(1). 325–325. 1 indexed citations
6.
Wang, Jing, Bing Shu, Dezhi Tang, et al.. (2023). The prevalence of osteoporosis in China, a community based cohort study of osteoporosis. Frontiers in Public Health. 11. 1084005–1084005. 42 indexed citations
7.
Liu, Can, Weilu Liu, Qinfeng Yang, et al.. (2023). Bone Homeostasis Modulating Orthopedic Adhesive for the Closed‐Loop Management of Osteoporotic Fractures. Small. 19(48). e2302704–e2302704. 15 indexed citations
8.
Yang, Ning, et al.. (2022). Melatonin Inhibits the Ferroptosis Pathway in Rat Bone Marrow Mesenchymal Stem Cells by Activating the PI3K/AKT/mTOR Signaling Axis to Attenuate Steroid‐Induced Osteoporosis. Oxidative Medicine and Cellular Longevity. 2022(1). 8223737–8223737. 54 indexed citations
9.
Liu, Ning, et al.. (2022). Bu-Gu-Sheng-Sui decoction promotes osteogenesis via activating the ERK/Smad signaling pathways. Frontiers in Pharmacology. 13. 976121–976121. 5 indexed citations
10.
Zhu, Liguo, et al.. (2022). Baduanjin exercise: A potential promising therapy toward osteoporosis. Frontiers in Medicine. 9. 935961–935961. 21 indexed citations
12.
Wang, Wei, Chen Bao, Yunming Li, et al.. (2022). Association of bone-related biomarkers with femoral neck bone strength. BMC Musculoskeletal Disorders. 23(1). 482–482. 2 indexed citations
13.
Wei, Xu, et al.. (2022). Quantitative Proteomics Revealed the Pharmacodynamic Network of Bugu Shengsui Decoction Promoting Osteoblast Proliferation. Frontiers in Endocrinology. 12. 833474–833474. 3 indexed citations
14.
Zhang, Fangqing, Qiuyue Li, Haonan Ruan, et al.. (2022). Total Flavonoids of Drynariae Rhizoma Improve Glucocorticoid-Induced Osteoporosis of Rats: UHPLC-MS-Based Qualitative Analysis, Network Pharmacology Strategy and Pharmacodynamic Validation. Frontiers in Endocrinology. 13. 920931–920931. 9 indexed citations
15.
Wei, Xu, Rui Xia, Feng Tian, et al.. (2022). microRNA-324-3p Promotes Osteoblasts Differentiation via Suppressing <i>SMAD7</i>. Journal of Hard Tissue Biology. 31(4). 263–268. 2 indexed citations
16.
Wei, Xu, et al.. (2021). Exploration of Experimental Teaching Reforms on C Programming Design Course. 330–333. 1 indexed citations
17.
Yang, Jiazhao, Xuefeng Zhou, Li Li, et al.. (2021). [Comparison of femoral neck system and inverted triangle cannulated screws fixations in treatment of Pauwels typle femoral neck fractures].. PubMed. 35(9). 1111–1118. 15 indexed citations
18.
Li, Meng, Hao Li, Lei Li, et al.. (2020). Cinnamtannin B-1 Prevents Ovariectomy-Induced Osteoporosis via Attenuating Osteoclastogenesis and ROS Generation. Frontiers in Pharmacology. 11. 1023–1023. 21 indexed citations
19.
Zhang, Yili, Junjie Jiang, Hao Shen, et al.. (2017). Total flavonoids from Rhizoma Drynariae (Gusuibu) for treating osteoporotic fractures: implication in clinical practice. Drug Design Development and Therapy. Volume 11. 1881–1890. 40 indexed citations
20.
Wu, Lin, Xiaohong Wang, Xu Wei, Farzin Farzaneh, & Rui‐Hua Xu. (2009). The Structure and Pharmacological Functions of Coumarins and Their Derivatives. Current Medicinal Chemistry. 16(32). 4236–4260. 257 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026